Latest Personalized medicine Stories
PHILADELPHIA and REHOVOT, Israel, March 12, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Ken Berlin, President and Chief Executive Officer of the Company, will present a corporate overview at the 25th Annual Roth Conference taking place from March 17-20, 2013 at the Ritz-Carlton Laguna Niguel in California. Mr. Berlin's presentation will take place on Tuesday, March 19(th) at...
This new Personalized Medicine Report delivers the latest and most up to date data on the personalized medicine market. This market research report also profiles 279 companies with estimates to 2021. Dublin, Ireland (PRWEB) March 08, 2013 Research and Markets has announced the addition of Jain PharmaBiotech's new report "Personalized Medicine - Scientific and Commercial Aspects" to their offering. The aim of this personalized medicine market research report or individualized...
TUCSON, Ariz., March 8, 2013 /PRNewswire/ -- For millions of patients, personalized healthcare, or fitting the right treatments to patients based on an individual's particular genetic make-up, means the difference between life and death. Our expanding knowledge of disease mechanisms and individual genetic variation, along with advanced testing technologies enables physicians to provide more precise diagnoses and targeted treatments for all patients, especially cancer patients....
March 10 Event at SGO Annual Meeting to Feature Presentations by Noted Experts in Gynecologic Oncology and Molecular Genetics IRVING, Texas, March 8, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, will sponsor an expert symposium, Integrating Next Generation Sequencing Into the Clinical Management of Gynecologic Cancers, at the 2013 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's...
Fosun Long March To Serve as Exclusive Distributor of MyCare(TM) Oncology Assays in China BETHLEHEM, Pa., March 5, 2013 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today it has received a $22.4 million (USD) strategic equity investment from Shanghai Fosun Pharmaceutical Co., Ltd. (Fosun Pharma: 600196.SH), a leading...
King Mithridates understood that poison is only as good as the dosage taken. Each day, he ingested small quantities of poison in order to become immunize and escape his court's plotters. Oncologists run up against the same principle when fighting cancer. Sometimes, a small dose of chemotherapy may induce dangerous resistance mechanisms in malignant cells, resulting in relapse. Now, EPFL research published in the journal PLOS ONE reports a tool that could simply and accurately determine the...
Role will help further advance revolutionary blood-based technology IRVING, Texas, March 5, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, announced today that it has named Joachim Schorr, PhD, as its Chief Scientific Officer. He joins Caris in this role after working as a consultant with the company during the past year. In this expanded capacity, Dr. Schorr's extensive expertise in the molecular...
HARTFORD, Conn., March 4, 2013 /PRNewswire/ -- Genomas(®), a biomedical company delivering personalized medicine to modern clinical practice, has been awarded clinical laboratory licenses in three of the most populous States. The company's Laboratory of Personalized Health received licenses from the New York Department of Health, the Florida Agency for Health Care Administration, and the California Department of Public Health. Gualberto Ruano, M.D., Ph.D., President of Genomas and...
HAYWARD, Calif., March 4th, 2013 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) announced today that they have entered into an agreement with The Johns Hopkins University on behalf of its Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins to use ACD's proprietary RNAscope® technology platform to validate novel biomarkers and drug targets for cancer immunotherapy. Cancer immunotherapy, which aims to mobilize a patient's immune system to fight cancer, has been gaining...
redOrbit Staff & Wire Reports - Your Universe Online An international team of researchers have produced what they are dubbing the “Google Maps” of human metabolism – the most comprehensive virtual recreation of the cellular chemical transformation ever crafted. The model is known as Recon 2, and according to the University of California, San Diego (UCSD) – one of the institutes behind the research – it could potentially be used to locate the causes of cancer, diabetes, and...
